Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Summary

To evaluate the safety and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).

Timeline

Start

2012-02

Primary completion

2013-05

Completion

2013-08

Outcome

Met primary endpoint

registry analysis (superiority or other test); Deoxycholic Acid Injection vs Placebo; p <0.001; Risk Ratio (RR) 3.702 (95% CI 2.808 to 4.880); Cochran-Mantel-Haenszel NCT01542034 ↗

registry analysis (superiority or other test); Deoxycholic Acid Injection vs Placebo; p <0.001; Cochran-Mantel-Haenszel NCT01542034 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Deoxycholic Acid	Unknown	—	—

Indications

No indication recorded.